An appraisal of lymph node ratio in colon and rectal cancer: Not one size fits all

International Journal of Colorectal Disease

Volumn 28, Issue 10, 2013, Pages 1377-1384

  Medani, M ^a   Kelly, Niall ^a   Samaha, George ^a   Duff, G ^a   Healy, Vourneen ^a   Mulcahy, Elizabeth ^a   Condon, Eoghan ^a   Waldron, David ^a   Saunders, Jean ^a,c   Coffey, J Calvin ^a,b  

^a UNIVERSITY HOSPITAL LIMERICK   (Ireland)

^b UNIVERSITY OF LIMERICK   (Ireland)

^c UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

Cancer; Colon; Lymph node ratio; Rectum; Survival

Indexed keywords

AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER EPIDEMIOLOGY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CLASSIFICATION; COLON CANCER; COLORECTAL CANCER; DISEASE FREE SURVIVAL; FEMALE; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; LYMPH NODE DISSECTION; LYMPH NODE RATIO; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RECTUM CANCER; REGRESSION ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

AGED; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DEMOGRAPHY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODES; MALE; MIDDLE AGED; RECTAL NEOPLASMS; REGRESSION ANALYSIS;

EID: 84884985614     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-013-1707-8     Document Type: Article

References (42)

1. Baxter NN, Virnig DJ, Rothenberger DA et al (2005) Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cacner Inst 97(3):219-225
2. Culligan K et al (2012) The mesocolon: a prospective observational study. Colorectal Dis 14(4):421-428, discussion 428-30
3. Culligan K et al (2012) Review of nomenclature in colonic surgery - Proposal of a standardised nomenclature based on mesocolic anatomy. Surgeon
4. Kim YS, Kim JH, Yoon SM et al (2009) Lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy. Int J Radiat Oncol Biol Phys 74:796-802
5. Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG (2005) Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 23(34):8706-8712
6. Elias E, Mukherji D, Faraj W, Khalife M, Dimassi H, Eloubeidy M, Hattoum H, Alfa GA, Melki C, Shamseddine A (2012) Lymph node ratio is an independent prognostic factor in Stage III colorectal cancer patients: a retrospective study from the Middle East. World J Surg Oncol 10(1):63
7. Greenberg R, Itah R, Ghinea R, Sacham-Shmueli E, Inbar R, Avital S (2011) Metastatic lymph node ratio (LNR) as a prognostic variable in colorectal cancer patients undergoing laparoscopic resection. Tech Coloproctol 15(3):273-279
8. Lee HY, Choi HJ, Park KJ et al (2007) Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma. Ann Surg Oncol 14:1712-1717
9. Park YH, Lee JI Park JK, Jo HJ, Kang WK, An CH (2011) Clinical significance of lymph node ratio in stage III colorectal cancer. J Korean Soc Coloproctol 27(5):260-265
10. Peng J, Xu Y, Guan Z, Zhu J, Wang M, Cai G, Sheng W, Cai S (2008) Prognostic significance of the metastatic lymph node ratio in node-positive rectal cancer. Ann Surg Oncol 15(11):3118-3123
11. Qui HB, Zhang LY, Li YF, Zhou ZW, Keshari RP, Xu RH (2011) Ratio of metastatic to resected lymph nodes enhances to predict survival in patients with stage III colorectal cancer. Ann Surg Oncol 18(6):1568-1574
12. Rosenberg R, Engel J, Bruns C, Heitland W, Hermes N, Jauch KW, Kopp R, Pütterich E, Ruppert R, Schuster T, Friess H, Hölzel D (2010) The prognostic value of lymph node ratio in a population-based collective of colorectal cancer patients. Ann Surg 251(6):1070-1078
13. Rosenberg R, Friederichs J, Schuster T et al (2008) Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-centre analysis of 3,026 patients over a 25-year time period. Ann Surg 248(6):968-978
14. Schumacher P, Dineen S, Branett C Jr et al (2007) The metastatic lymph node ration predicts survival in colon cancer. Am J Surg 194:827-832
15. Shao XL, Han HQ, He XL, Fu Q, Ly YC, Liu G (2011) Impact of number of retrieved lymph nodes and lymph node ratio on the prognosis in patients with stage II and III colorectal cancer. Zhonghua Wei Chang Wai Ke Za Zhi 14(4):249-253
16. Tong LL, Gao P, Wang ZN, Song YX, Xu YY, Sun Z, Xing CZ, Wang X, Xu HM (2011) Can lymph node ratio take the place of pN categories in the UICC/AJCC TNM classification system for colorectal cancer? Ann Surg Oncol 18(9):2453-2460
17. Vaccaro CA, Im V, Rossi GL, Quintana GO, Benati ML, PerezdeArenaza D, Bonadeo FA (2009) Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons. Dis Colon Rectum 52(7):1244-1250
18. Wang J, Hassett JM, Dayton MT, Kulaylat MN (2008) Lymph node ratio: role in the staging of node-positive colon cancer. Ann Surg Oncol 15:1600-1608
19. Ceelen W, Van Nieuwenhove Y, Pattyn P (2010) Prognostic value of the lymph node ratio in stage III colorectal cancer: a systematic review. Ann Surg Oncol 17(11):2847-2855
20. Bujko K, Nowacki MP, Nasierowska-Guttmejer A et al (2005) Prediction of mesorectal nodal metastases after chemoradiation for rectal cancer: results of a randomised trial: implication for subsequent local excision. Radiother Oncol 76(3):234-240
21. Doll D, Gertler R, Maak M et al (2009) Reduced lymph node yield in rectal carcinoma specimen after neoadjuvant radiochemotherapy has no prognostic relevance. World J Surg 33(2):340-347
22. Latkauskas T, Lizdenis P, Janciauskiene R et al (2010) Lymph node retrieval after resection of rectal cancer following preoperative chemoradiotherapy. Medicina (Kaunas) 46(5):299-304
23. Habr-Gama A et al (2008) Absence of lymph nodes in the resected specimen after radical surgery for distal rectal cancer and neoadjuvant chemoradiation therapy: what does it mean? Dis Colon Rectum 51(3):277-283
24. Samowitz WS et al (2000) Relationship of K-ras mutations in colon cancers to tumour location, stage and survival: a population-based study. Cancer Epidemiol Biomarkers Prev 9(11):1193-1197
25. Kaji E et al (2011) Analysis of Kras, BRAF and PIK3CA mutations in laterally-spreading tumours of the colorectum. J Gastroenterol Hepatol 26(3):599-607
26. Zlobec I et al (2010) Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer. Int J Cancer 127(11):2569-2575
27. Elnatan J, Goh HS, Smith DR (1996) C-KI-RAS activation and the biological behaviour of proximal and distal colonic adenocarcinomas. Eur J Cancer 32A(3):491-497
28. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M (2002) The AJCC Cancer Staging Manual, 6th edn. Springer, New York, pp 113-124
29. Cohen AM, Tremiterra S, Candela F et al (1991) Prognosis of node-positive colon cancer. Cancer 67(7):1859-1861
30. Mekenkamp LJ, van Krieken JH, Marijnen CA (2009) Lymph node retrieval in rectal cancer is dependent on many factors - the role of the tumour, the patient, the surgeon, the radiotherapist and the pathologist. Am J Surg Pathol 33(10):1547-1553
31. Kozak KR, Moody JS (2008) The impact of T and N stage on long-term survival of rectal cancer patients in the community. J Surg Oncol 98(3):161-166
32. Joseph NE, Sigurdson ER, Hanlon AL et al (2003) Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection. Ann Surg Oncol 10:213-218
33. Goldstein NS, Sanford W, Coffey M, Layfield LJ (1996) Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol 106:209-216
34. Wong JH, Severino R, Honnebier MG, Tom P, Namiki TS (1999) Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol 17:2896-2900
35. Berger AC, Watson JC, Ross EA, Hoffman JP (2004) The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg 70:235-240
36. Inoue K, Nakane Y, Iiyama H et al (2002) The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 9:27-34
37. Nitti D, Marchet A, Olivieri M et al (2003) Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol 10:1077-1085
38. Noue K, Nakane Y, Iiyama H et al (2002) The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 9:27-34
39. Voordeckers M, Vinh-Hung V, Van de Steene J, Lamote J, Storme G (2004) The lymph node ratio as prognostic factor in node-positive breast cancer. Radiother Oncol 70:225-230
40. Powell AGMT, W.R., McKee RF, Anderson JH, Going JJ, Edwards J, Horgan PG (2012) The relationship between tumour site, clinicopathological characteristics and cancerspecific survival in patients undergoing surgery for colorectal cancer. Colorectal Dis. 16 epub ahead of print
41. Wang H, Wei XZ, Fu CG, Zhao RH, Cao FA (2010) Patterns of lymph node metastasis are different in colon and rectal carcinomas. World J Gastroenterol 16(42):5375-5379
42. Kang J, Hur H, Min BS, Lee KY, Kim NK (2011) Prognostic impact of the lymph node ratio in rectal cancer patients who underwent preoperative chemoradiation. J Surg Oncol 104(1):53-58